NDC 72974-120

Orgovyx

Relugolix

Orgovyx is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Myovant Sciences, Inc.. The primary component is Relugolix.

• Product ID: 72974-120_05bc4a55-f7d7-4349-a7f6-86185c334d56
• NDC: 72974-120
• Product Type: Human Prescription Drug
• Proprietary Name: Orgovyx
• Generic Name: Relugolix
• Dosage Form: Tablet, Film Coated
• Route of Administration: ORAL
• Marketing Start Date: 2020-12-18
• Marketing Category: NDA / NDA
• Application Number: NDA214621
• Labeler Name: Myovant Sciences, Inc.
• Substance Name: RELUGOLIX
• Active Ingredient Strength: 120 mg/1
• Pharm Classes: Breast Cancer Resistance Protein Inhibitors [MoA], Cytochrome P450 2B6 Inducers [MoA], Cytochrome P450 3A Inducers [MoA], Decreased GnRH Secretion [PE], Gonadotropin Releasing Hormone Receptor Antagonist [EPC], Gonadotropin Releasing Hormone Receptor Antagonists [MoA], P-Glycoprotein Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 72974-120-01

30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72974-120-01)

• Marketing Start Date: 2020-12-18
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details